Loading news...
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Elo Mutual Pension Insurance Co grew its holdings in shares of Cardinal Health, Inc. (NYSE: CAH) by 43.5% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The firm owned 49,298 shares of the company's stock after buying an additional 14,954 shares during the period. Elo Mutual
Cardinal Health, Inc. (NYSE: CAH - Get Free Report)'s stock price hit a new 52-week high on Monday after Leerink Partners raised their price target on the stock from $268.00 to $275.00. Leerink Partners currently has an outperform rating on the stock. Cardinal Health traded as high as $232.97 and last traded at $232.1990, with a
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) is up 9.39% YTD in 2026, decisively outperforming SPY's 1.08%. Dividend Aristocrats are regaining momentum after a weak 2025, with 55 outpacing SPY and 39 posting double-digit gains this year already. Dividend growth is lagging, with 2026's average increase currently at 3.22%, below last year's trend and potentially signaling headwinds.
The 2025 Q4 earnings season is pretty much over following the highly-awaited NVIDIA release. Throughout the period, these three releases have stood out.
Cozad Asset Management Inc. lifted its position in Cardinal Health, Inc. (NYSE: CAH) by 23.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 32,266 shares of the company's stock after purchasing an additional 6,185 shares during the quarter.
New analysis shows biosimilars are projected to strengthen cost savings and provider confidence across the healthcare ecosystem, with oncology leading in adoption and accessibility gains. DUBLIN, Ohio, Feb. 24, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today released its 2026 Biosimilars Report: Driving access and patient outcomes in physician practices, which highlights the substantial savings biosimilars have delivered to the U.S. healthcare system and the strong confidence providers have in these treatments.
Counterpoint Mutual Funds LLC raised its holdings in shares of Cardinal Health, Inc. (NYSE: CAH) by 51.7% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 17,251 shares of the company's stock after buying an additional 5,877 shares during the period. Counterpoint Mutual
Raiffeisen Bank International AG reduced its stake in shares of Cardinal Health, Inc. (NYSE: CAH) by 71.6% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,633 shares of the company's stock after selling 4,108 shares during the quarter. Raiffeisen Bank International
Axxcess Wealth Management LLC cut its holdings in Cardinal Health, Inc. (NYSE: CAH) by 20.7% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,141 shares of the company's stock after selling 3,166 shares during the period. Axxcess Wealth Management LLC's
The 2025 Q4 earnings cycle keeps rolling along, with overall growth remaining strong. Specifically, these companies knocked it out of the park, with both also sporting a favorable Zacks Rank.
BOOT joins EAT, TPR and CAH on a screen for strong interest coverage, solid volume and growth, spotlighting four stocks that made the cut.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Assetmark Inc. decreased its holdings in Cardinal Health, Inc. (NYSE: CAH) by 14.0% during the undefined quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 68,316 shares of the company's stock after selling 11,101 shares during the quarter. Assetmark Inc.'s holdings in Cardinal Health were
Atria Investments Inc raised its holdings in shares of Cardinal Health, Inc. (NYSE: CAH) by 17.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 27,709 shares of the company's stock after buying an additional 4,073 shares during
LTM, ING and CAH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 13, 2026.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
DUBLIN, Ohio, Feb. 12, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on April 15, 2026 to shareholders of record at the close of business on April 1, 2026.